Welcome to our latest episode featuring Professor Emmanouil Tsochatzis, a distinguished Professor of Hepatology and Honorary Consultant at the UCL Institute for Liver and Digestive Health in the Royal Free Hospital. Today, we embark on an exploration of the profound impact of Metabolic-Associated Steatohepatitis (MASH) on individuals grappling with type 2 diabetes mellitus. Prepare to delve into the intricate details of this pressing issue as Professor Tsochatzis sheds light on the burden of MASH, unraveling its complexities and implications for those affected. Moreover, we'll uncover his latest groundbreaking research, recently published in The Lancet, advocating for the implementation of liver health checks in people with type 2 diabetes. Join us for an enlightening discussion at the forefront of liver health and metabolic diseases, as we navigate the terrain of MASH and its intersection with diabetes. Stay tuned for insights that could redefine our approach to managing these conditions.

Discover the latest insights in viral hepatitis control in Africa with Dr. Yusuke Shimakawa, a senior epidemiologist at the Institut Pasteur, Paris. In this episode, gain privileged access to Dr. Shimakawa's expertise as he navigates the complexities of hepatitis B and discusses tailored care strategies specifically for Africa. Tune in to deepen your understanding of this crucial public health issue.

We are thrilled to have the privilege of hosting Prof. Juan Pablo Arab, a distinguished expert in alcohol-associated liver disease from the Schulich School of Medicine at Western University, Canada. In this enlightening episode, Prof. Arab unveils groundbreaking insights from his recent publication in Hepatology, shedding light on the intricate molecular mechanisms underlying alcohol abstinence and relapse in individuals grappling with alcohol-associated liver disease. Prepare to be captivated as we explore the forefront of research with one of the foremost authorities in the field.

In this highly anticipated episode, we extend a warm welcome to Prof Rashid Lui, a distinguished gastrointestinal oncologist hailing from The Chinese University of Hong Kong. Join us as he delves into his comprehensive review on the pivotal role of the gut microbiome and fecal microbiota transplantation in addressing liver cancer and associated complications. Prof Lui offers captivating insights into the dynamic landscape of gut microbiome research, illuminating the path towards innovative approaches in liver health management.

Prepare for an enlightening journey as we dive into a riveting discussion with Prof Loretta Jophlin, an esteemed transplant hepatologist from the Trager Transplant Center, Jewish Hospital and the University of Louisville, Kentucky. Join us as she unveils invaluable insights into the latest ACG Clinical Guideline for Alcohol-Associated Liver Disease, offering a glimpse into cutting-edge advancements and best practices in liver health management.

We are truly honored to welcome a luminary in the field of hepatology, none other than Prof Kris Kowdley. With a career spanning decades, Prof Kowdley stands as a trailblazer in advancing our understanding of liver health. As the Director of Liver Institute Northwest and a distinguished Professor at Elson S Floyd College of Medicine at Washington State University, his expertise is unparalleled. Today, we have the distinct privilege of delving into his groundbreaking research, recently published in the prestigious New England Journal of Medicine, on the Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.

We are delighted to host Prof Ana Lleo, a distinguished expert in autoimmune liver disease from Humanitas University. Join us for an enlightening discussion as we delve into her recent study published in the Journal of Hepatology. In this episode, we explore the intricacies surrounding the incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis. Don't miss out on the opportunity to gain valuable insights in this must-listen episode!

Join us for an exciting episode with Dr. Ciro Celsa from the Università degli Studi di Palermo as he unveils his latest research published in the Journal of Hepatology. Delve into the distinct characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma compared to other advanced solid tumors. Don't miss this insightful discussion on the forefront of medical advancements.